Rv2449c is annotated as a putative trans-acting enoyl reductase involved in the fatty acid synthesis (FAS-II) pathway. Enoyl reductases catalyze the final step of the elongation cycle, reducing trans-2-enoyl-acyl carrier protein (ACP) to acyl-ACP using NADH or NADPH as a cofactor . Key features include:
Enoyl reductases like Rv2449c typically employ a conserved tyrosine residue (e.g., Y158 in Mtb InhA) to facilitate proton transfer during substrate reduction . Structural studies of related enzymes (e.g., FabI, FabV) suggest a Rossmann fold for NADH binding and a water-mediated protonation pathway .
Fatty Acid Synthesis: Rv2449c is implicated in mycolic acid biosynthesis, essential for Mtb’s cell wall integrity and antibiotic resistance .
Regulatory Interactions: Proteins like ClpC1 (a protease unfoldase) modulate Rv2449c levels, indicating its sensitivity to proteostatic stress .
Enoyl reductases are validated targets for antimycobacterial agents (e.g., isoniazid targets InhA, Rv1484) . While Rv2449c’s exact role in drug resistance remains uncharacterized, its structural homology to FabI enzymes suggests potential for inhibitor development .
Mechanistic Studies: The catalytic residues and substrate preferences of Rv2449c require experimental validation.
Inhibitor Screening: High-throughput assays using recombinant Rv2449c could identify novel antitubercular compounds .
Structural Biology: Cryo-EM or X-ray crystallography would clarify its active-site architecture and cofactor interactions .
KEGG: mtu:Rv2449c
STRING: 83332.Rv2449c
Rv2449c is a putative trans-acting enoyl reductase from Mycobacterium tuberculosis. It is a full-length protein consisting of 419 amino acids (residues 1-419) and can be produced as a recombinant protein with a His-tag using E. coli expression systems . As a putative enoyl reductase, it likely plays a role in mycobacterial fatty acid metabolism, which is crucial for cell wall synthesis and potentially virulence.
The protein structure has not been fully characterized in the available literature, but researchers can express it as a recombinant protein for structural and functional studies. The protein's relatively large size (419 amino acids) suggests it may have multiple domains or complex folding patterns that contribute to its enzymatic activity.
While direct evidence linking Rv2449c to the Clp proteolytic system is not explicitly stated in the available research, the connection is worth investigating. Mycobacterium tuberculosis possesses a well-orchestrated Clp (caseinolytic protease) proteolytic machinery consisting of two components: a barrel-shaped heterotetradecameric protease core (ClpP1 and ClpP2 subunits) and hexameric ring-like ATP-dependent unfoldases (ClpX or ClpC1) .
The Clp system regulates dosage-sensitive proteins and participates in proteostasis network maintenance. Rv2449c could potentially:
Be a substrate of the Clp system, regulated through proteolytic degradation
Function in metabolic pathways that intersect with proteins regulated by ClpC1
Be part of stress response mechanisms that involve the Clp machinery
Experimental approaches such as knockdown studies of clpC1 combined with proteomics analysis could help identify whether Rv2449c levels are affected by Clp system perturbations.
As a putative trans-acting enoyl reductase, Rv2449c likely participates in fatty acid biosynthesis or modification pathways that are essential for mycobacterial cell wall synthesis. While specific pathway information for Rv2449c is not detailed in the available search results, enoyl reductases typically catalyze the final reductive step in fatty acid elongation cycles.
Potential metabolic contexts for Rv2449c include:
Mycolic acid biosynthesis, which is crucial for the distinctive mycobacterial cell envelope
Fatty acid elongation pathways that contribute to membrane phospholipid synthesis
Specialized lipid production involved in virulence or stress responses
Determining the exact metabolic role of Rv2449c would require experimental validation through enzymatic assays, pathway reconstitution, and substrate identification studies.
Based on available data, E. coli has been successfully used as an expression host for recombinant His-tagged Rv2449c protein . When designing expression systems for mycobacterial proteins like Rv2449c, researchers should consider:
Codon optimization: Adapting the coding sequence to match E. coli codon usage preferences
Expression vectors: Selecting appropriate promoters (T7, tac) and fusion tags (His-tag for purification)
Host strains: Using specialized E. coli strains designed for recombinant protein expression
Induction conditions: Optimizing temperature, inducer concentration, and induction timing
The expression conditions reported for successful production of Rv2449c are summarized in the following table:
| Parameter | Condition |
|---|---|
| Host organism | E. coli |
| Protein length | Full length (1-419 amino acids) |
| Fusion tag | His-tag |
| Source species | Mycobacterium tuberculosis |
| Product format | Recombinant protein |
While the search results don't specifically mention CRISPR interference (CRISPRi) studies of Rv2449c, this approach has been effectively used to study essential genes in Mycobacterium tuberculosis . CRISPRi could be applied to study Rv2449c function through:
Conditional gene silencing: Using anhydrotetracycline (ATc)-dependent suppression to achieve fine-tuned control of Rv2449c expression
Partial knockdown: Reducing gene expression without completely eliminating it, allowing study of essential genes
Time-course experiments: Activating suppression at different growth phases to determine stage-specific functions
Phenotypic analysis: Assessing growth rate, morphology, and stress responses upon Rv2449c depletion
A CRISPRi approach for Rv2449c would involve:
Designing guide RNAs targeting the Rv2449c promoter or early coding region
Constructing a CRISPRi vector with the dCas9 gene and the guide RNA
Transforming the vector into Mycobacterium tuberculosis
Inducing gene silencing with ATc and monitoring phenotypic changes
This methodology has successfully demonstrated the essentiality of clpC1 in mycobacterial growth and survival in macrophages, with 70-80% suppression achieved after 7 days of treatment with 50 ng/ml ATc .
Based on proteomics methodologies used in mycobacterial research, several approaches could be effective for identifying Rv2449c interaction partners:
Isobaric tags for relative and absolute quantitation (iTRAQ)-based LC-MS: This approach has been successfully used to identify proteins that accumulate in clpC1 and clpP2 knockdown strains . A similar approach could identify changes in the proteome upon Rv2449c manipulation.
Co-immunoprecipitation with LC-MS/MS analysis: Using antibodies against tagged Rv2449c to pull down protein complexes, followed by mass spectrometry identification.
Bacterial two-hybrid systems: Screening for direct protein-protein interactions involving Rv2449c.
Proximity-based labeling approaches: Using BioID or APEX2 fusions with Rv2449c to identify proximal proteins in the native environment.
The iTRAQ-based approach used for studying the Clp system identified:
317 proteins accumulated in clpC1 knockdown
359 proteins accumulated in clpP2 knockdown
This suggests substantial overlap in the substrates processed by different components of the Clp machinery, and similar approaches could reveal functional relationships for Rv2449c.
When analyzing enzymatic activity data for Rv2449c or similar proteins, researchers should implement robust statistical approaches that account for variability and experimental limitations. Based on statistical principles outlined in search result , the following approaches are recommended:
Descriptive statistics:
Measures of central tendency (mean, median, mode) to summarize performance levels
Measures of variability (range, variance, standard deviation) to describe data spread
Inferential statistics:
Null and alternative hypothesis formulation
Selection of appropriate statistical tests based on data distribution
Determination of statistical significance through p-value calculation
Experimental design considerations:
Power analysis to determine adequate sample sizes
Effect size calculations to quantify the magnitude of observed effects
Assessment of Type I (false positive) and Type II (false negative) error rates
The importance of variability cannot be overstated—as noted in search result , when variability is large, measures of central tendency become less reliable guides to representative performance. This principle applies directly to enzymatic assays, where reducing variability is essential for detecting treatment effects.
To minimize variability in experiments involving Rv2449c or similar mycobacterial proteins, researchers should implement several strategies derived from experimental design principles :
Control over experimental conditions:
Select reliable dependent variables and standardized measurement techniques
Provide uniform instructions and standardized experimental procedures
Control obtrusive and extraneous experimental stimuli
Careful sample preparation:
Standardize protein expression and purification protocols
Verify protein quality and concentration through multiple methods
Prepare reagents fresh and under identical conditions
Robust experimental design:
Include appropriate technical and biological replicates
Randomize sample processing order to avoid systematic bias
Use internal standards and calibration curves for quantitative assays
Data collection and analysis:
Implement consistent data collection procedures
Use statistical methods appropriate for the data distribution
Apply transformations if necessary to meet statistical assumptions
As noted in search result , "much of this text focuses, directly or indirectly, on procedures for reducing variability—for example, selecting a reliable dependent variable, providing uniform instructions and standardized experimental procedures, and controlling obtrusive and extraneous experimental stimuli."
When studying enzymatic activity of Rv2449c, several critical controls should be included:
Negative controls:
Reaction mixtures without enzyme (substrate-only controls)
Heat-inactivated enzyme preparations
Reactions with known inhibitors of similar enzymes
Positive controls:
Well-characterized enzymes with similar activity
Verified enzyme preparations with known activity levels
Standard curves with purified reaction products
Specificity controls:
Substrate specificity tests using related compounds
Cofactor dependency tests (NAD+/NADH, metal ions)
pH and temperature optima determinations
System controls:
Empty vector controls when using expression systems
Wild-type strain comparisons when using genetic approaches
Vehicle controls for any additives or solvents
Technical controls:
Instrument calibration standards
Inter-assay and intra-assay variability assessments
Time-course measurements to ensure linearity of the assay
These controls align with the rigorous experimental approaches described for studying essential mycobacterial proteins such as components of the Clp system .
To investigate Rv2449c's potential role in macrophage survival, researchers can adapt methodologies used for studying the Clp system :
Conditional gene silencing approach:
Generate CRISPRi-based knockdown strains for Rv2449c
Verify knockdown efficiency at the mRNA and protein levels
Assess growth in synthetic media before proceeding to infection models
Macrophage infection protocol:
Infect THP-1 macrophages (or other relevant cell lines) with control and Rv2449c-depleted bacteria
Use appropriate multiplicity of infection (MOI), such as 1:2 as used for ClpC1 studies
Monitor bacterial survival at multiple time points (days 0, 1, 3, 5, and 7)
Quantification methods:
Perform CFU plating of macrophage lysates to enumerate viable bacteria
Calculate log₁₀ CFU/well at each time point
Compare growth trajectories between control and knockdown strains
Complementary approaches:
Analyze macrophage responses (cytokine production, phagosomal maturation)
Assess bacterial stress responses within the intracellular environment
Investigate potential metabolic adaptations upon Rv2449c depletion
For reference, in ClpC1 knockdown studies, control Mtb showed substantial growth in THP-1 macrophages (increasing from 3.92 to 5.25 log₁₀ CFU/well over 7 days), while ClpC1-depleted bacteria showed minimal growth (3.79 to 4.24 log₁₀ CFU/well) .
To determine if Rv2449c is a substrate of the Clp proteolytic system, researchers could employ several complementary approaches based on methodologies described for studying Clp substrates :
Proteomic analysis of accumulating proteins:
Generate conditional knockdown strains of clpC1 and clpP2
Perform iTRAQ-based LC-MS analysis of whole-cell lysates
Compare protein abundance profiles between control and knockdown strains
Identify whether Rv2449c accumulates upon Clp system depletion
Direct interaction studies:
Express and purify tagged versions of ClpC1 and Rv2449c
Perform in vitro pull-down assays to detect direct interactions
Use surface plasmon resonance or microscale thermophoresis to quantify binding affinities
Degradation assays:
Reconstitute the Clp proteolytic system in vitro
Monitor degradation of purified Rv2449c in the presence of Clp components
Use Western blotting or fluorescence-based assays to quantify degradation rates
In vivo stability measurements:
Express tagged Rv2449c in wild-type and Clp-depleted mycobacteria
Perform protein synthesis inhibition (e.g., with chloramphenicol)
Monitor Rv2449c turnover rates in different genetic backgrounds
These approaches could reveal whether Rv2449c is among the proteins regulated by the Clp system, which has been shown to affect numerous proteins involved in intermediary metabolism, respiration, and lipid metabolism .
The Clp proteolytic system plays a crucial role in regulating dosage-sensitive proteins in Mycobacterium tuberculosis. Search result specifically mentions that "the Clp machinery regulates dosage-sensitive proteins such as the small heat shock protein Hsp20, which exists in a dodecameric conformation."
Key aspects of this regulation include:
Proteostasis maintenance:
Targeted protein degradation:
The ClpC1 unfoldase recognizes and unfolds specific substrate proteins
These unfolded proteins are then transferred to the ClpP1P2 protease core for degradation
Substrate recognition may involve specific sequence motifs or structural features
Stress response regulation:
The Clp system helps bacteria adapt to changing environmental conditions
It may regulate the turnover of stress-induced proteins when conditions normalize
This function is crucial for mycobacterial survival in the host environment
Implications for Rv2449c research:
If Rv2449c is a dosage-sensitive protein, its levels might be carefully regulated by the Clp system. Proteomics analysis has shown that 69% of proteins that accumulate in clpC1-knockdown strains also accumulate in clpP2-knockdown strains, suggesting substantial overlap in the substrate pools . Among these are proteins involved in intermediary metabolism and respiration (37%), lipid metabolism (24%), and cell wall processes (24%) .
Understanding whether Rv2449c falls into these categories could provide insights into its regulation and functional importance in mycobacterial physiology.
Several significant challenges exist in studying potentially essential mycobacterial proteins like Rv2449c:
Genetic manipulation constraints:
Expression and purification challenges:
Mycobacterial proteins often have unusual codon usage or require specific folding conditions
Obtaining sufficient quantities of properly folded protein for biochemical studies can be difficult
Post-translational modifications may differ between heterologous expression systems and native conditions
Functional characterization limitations:
Enzymatic assays require identification of appropriate substrates
In vitro activity may not fully reflect in vivo function
Interaction partners in the complex mycobacterial cellular environment may be difficult to identify
Physiological relevance assessment:
Connecting biochemical activities to physiological roles requires multiple approaches
Compensatory mechanisms may mask phenotypes in partial knockdown systems
Translation between in vitro, ex vivo, and in vivo models presents challenges
The study of ClpC1 demonstrated how essential genes can be investigated using CRISPRi-based approaches, achieving 70-80% suppression after 7 days of ATc treatment . Similar approaches could be adapted for Rv2449c research.
Proteomics approaches offer powerful tools for elucidating Rv2449c function, as demonstrated by their successful application to understanding the Clp system :
Global protein abundance profiling:
iTRAQ-based quantitative proteomics to identify changes upon Rv2449c manipulation
Comparison of protein abundance profiles between wild-type and Rv2449c-depleted strains
Identification of proteins indirectly affected by Rv2449c function
Protein interaction network mapping:
Affinity purification coupled with mass spectrometry to identify Rv2449c interactors
Proximity-labeling approaches to identify proteins in the same subcellular compartment
Cross-linking mass spectrometry to capture transient interactions
Post-translational modification analysis:
Identification of modifications on Rv2449c that might regulate its activity
Assessment of how Rv2449c might affect modification patterns of other proteins
Correlation of modifications with specific growth conditions or stress responses
Functional classification of affected proteins:
Pathway analysis of proteins affected by Rv2449c manipulation
Identification of enriched biological processes among differentially abundant proteins
Integration with transcriptomic data to understand regulatory networks
The proteomics approach used for ClpC1 studies identified fundamental categories of affected proteins, including those involved in intermediary metabolism and respiration (37%), lipid metabolism (24%), cell wall processes (24%), and unknown functions (27%) . Similar categorization of Rv2449c-dependent proteins could provide crucial insights into its functional role.
When researchers encounter contradictory findings about Rv2449c function, several statistical considerations derived from search result become essential:
Variability assessment:
Effect size evaluation:
Calculate effect sizes to standardize the magnitude of observed effects
Compare effect sizes across studies to identify potential sources of discrepancy
Consider whether statistically significant results are also biologically meaningful
Statistical power analysis:
Assess whether studies had sufficient power to detect effects of interest
Evaluate whether negative findings might result from Type II errors
Consider sample sizes in relation to expected effect sizes
Experimental design comparison:
Meta-analytical approach:
Systematically compare results across multiple studies
Weight findings based on methodological quality and sample size
Identify moderator variables that might explain contradictory results
Null hypothesis significance testing:
Consider the formulation of null and alternative hypotheses
Evaluate the appropriateness of statistical tests used
Assess whether multiple comparison corrections were applied when necessary
Understanding that "two factors are commonly involved in assessing the effects of an experimental variable: a measure of centrality, such as the mean, median, or proportion; and a measure of variability, such as the standard deviation" is crucial when interpreting contradictory findings about protein function.